idarucizumab
US/ˌaɪ.də.ɹuˈsɪz.əˌmæb/
idarucizumab noun: a monoclonal antibody designed for the reversal of anticoagulant effects of dabigatran.
Noun
idarucizumab (uncountable)
- A monoclonal antibody designed for the reversal of anticoagulant effects of dabigatran.
Origin of idarucizumab
From idaru- (of unknown origin) + -ci- (“cardiovascular”) + -zumab (“humanized monoclonal antibody”).
Questions about idarucizumab
- What does idarucizumab mean?
- Idarucizumab means a monoclonal antibody designed for the reversal of anticoagulant effects of dabigatran.
- What part of speech is idarucizumab?
- Idarucizumab is a noun.
- How do you pronounce idarucizumab?
- Idarucizumab is pronounced /ˌaɪ.də.ɹuˈsɪz.əˌmæb/ (US).
Words near idarucizumab in the dictionary
Source and license
Adapted from Wiktionary: idarucizumab (page history and authors). Text available under the Creative Commons Attribution-ShareAlike 4.0 license. Word.ws reformatted the entry and added links. Wiktionary data of 2026-09-02.
Last updated:
Cite this entry: “idarucizumab.” Word.ws, https://word.ws/idarucizumab. Based on Wiktionary, CC BY-SA 4.0.
